Envista Holdings Corporation $NVST Shares Sold by Teacher Retirement System of Texas

Teacher Retirement System of Texas decreased its position in shares of Envista Holdings Corporation (NYSE:NVST) by 14.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,396 shares of the company’s stock after selling 13,042 shares during the period. Teacher Retirement System of Texas’ holdings in Envista were worth $1,473,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in NVST. Parallel Advisors LLC raised its holdings in Envista by 100.1% during the second quarter. Parallel Advisors LLC now owns 2,792 shares of the company’s stock worth $55,000 after purchasing an additional 1,397 shares in the last quarter. FourThought Financial Partners LLC bought a new position in shares of Envista in the first quarter valued at $180,000. Vestcor Inc bought a new position in shares of Envista in the first quarter valued at $211,000. Aigen Investment Management LP bought a new position in shares of Envista in the first quarter valued at $274,000. Finally, State of Wyoming increased its holdings in shares of Envista by 121.1% in the first quarter. State of Wyoming now owns 16,911 shares of the company’s stock valued at $292,000 after buying an additional 9,264 shares in the last quarter.

Analyst Ratings Changes

NVST has been the topic of several research reports. Zacks Research cut Envista from a “strong-buy” rating to a “hold” rating in a report on Monday, September 15th. Piper Sandler upped their price target on Envista from $17.00 to $19.00 and gave the company a “neutral” rating in a report on Friday, August 1st. UBS Group upped their price target on Envista from $18.00 to $22.00 and gave the company a “neutral” rating in a report on Tuesday, July 29th. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a report on Saturday. Finally, Stifel Nicolaus set a $25.00 target price on shares of Envista in a research note on Thursday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Envista currently has a consensus rating of “Hold” and an average price target of $21.33.

Envista Price Performance

Shares of NYSE:NVST opened at $20.17 on Wednesday. The company’s fifty day moving average is $20.48 and its two-hundred day moving average is $19.49. The company has a quick ratio of 2.08, a current ratio of 2.44 and a debt-to-equity ratio of 0.46. Envista Holdings Corporation has a 12-month low of $14.22 and a 12-month high of $22.68. The company has a market cap of $3.35 billion, a P/E ratio of 63.04, a price-to-earnings-growth ratio of 1.09 and a beta of 1.01.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.27 by $0.05. Envista had a net margin of 2.11% and a return on equity of 4.84%. The business had revenue of $669.90 million for the quarter, compared to analysts’ expectations of $639.49 million. During the same period in the previous year, the company posted $0.12 EPS. Envista’s revenue was up 11.5% on a year-over-year basis. Equities analysts expect that Envista Holdings Corporation will post 1 earnings per share for the current fiscal year.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.